论文部分内容阅读
目的探讨综合干预个体化治疗高血压的控制率(治疗达标率)及并发症的发生率。方法将128例高血压患者分为3组,第1组(治疗组)42例,给予综合药物治疗及健康教育;第2组(治疗组)44例,给予综合药物治疗及不完全健康教育;第3组(对照组)42例,仅给予综合药物治疗。随访2年,观察患者治疗的达标率及并发症发生率。结果第1组治疗达标率为71.43%,心脑血管病的发生率为2.38%;第2组治疗达标率为54.54%,心脑血管病的发生率为4.55%;第3组治疗达标率为33.3%,心脑血管病的发生率为19.05%。第1组与第3组控制率差异有统计学意义(χ2=12.22,P<0.01),第2组与第3组控制率差异有统计学意义(χ2=3.92,P<0.05),第1组与第2组控制率差异无统计学意义(χ2=2.62,P>0.05)。结论综合干预个体化治疗能提高疗效并降低心脑血管并发症的发生。
Objective To explore the comprehensive intervention for individualized control of hypertension control rate (treatment compliance rate) and the incidence of complications. Methods A total of 128 hypertensive patients were divided into 3 groups, 42 cases in the first group (treatment group) were given comprehensive medical treatment and health education; 44 cases in the second group (treatment group) were given comprehensive medical treatment and incomplete health education; Group 3 (control group) 42 cases, only given comprehensive medical treatment. The patients were followed up for 2 years to observe the compliance rate and complication rate of patients. Results The compliance rate of group 1 was 71.43% and the incidence of cardio-cerebrovascular disease was 2.38%. The compliance rate of group 2 was 54.54% and the incidence of cardio-cerebrovascular disease was 4.55%. The compliance rate of group 3 was 33.3%, the incidence of cardiovascular disease was 19.05%. There were significant differences in the control rates between the first group and the third group (χ2 = 12.22, P <0.01), the second group and the third group (χ2 = 3.92, P <0.05) There was no significant difference in the control rate between the two groups (χ2 = 2.62, P> 0.05). Conclusion Comprehensive interventions can improve the curative effect and reduce the incidence of cardiovascular and cerebrovascular complications.